Welcome to Spektrum der Augenheilkunde, a distinguished journal published by SPRINGER WIEN, dedicated to the field of ophthalmology since its inception in 1987. With an ISSN of 0930-4282 and an E-ISSN of 1613-7523, this journal is recognized for its commitment to publishing original research, reviews, and clinical studies that address current and emerging topics in eye health and treatment. Although classified in the Q4 category for ophthalmology as per the latest 2023 rankings, it serves as a valuable platform for researchers, professionals, and students looking to contribute to and expand their knowledge in this vital area of medicine. Based in Austria and accessible through various academic databases, the journal aims to foster communication among professionals and advance the understanding of ocular diseases, innovative therapies, and clinical best practices.

International Ophthalmology is a prestigious journal published by Springer, dedicated to advancing the field of ophthalmology through the dissemination of high-quality research and clinical studies. With an ISSN of 0165-5701 and an E-ISSN of 1573-2630, this journal has been a vital resource since its inception in 1978, serving the global community of ophthalmologists, researchers, and healthcare professionals. The journal holds a significant Q2 ranking in the category of ophthalmology and has achieved a commendable position as #56 in Scopus's rankings, placing it within the top tier of its field. Although it does not offer open-access options, articles published in International Ophthalmology are widely cited and respected, playing a crucial role in the ongoing dialogue regarding contemporary ophthalmic practices and innovations. With a broad scope covering all aspects of eye care, this journal is essential for those aiming to keep abreast of the latest developments and research findings that shape the future of vision science and clinical practice.

CURRENT OPINION IN OPHTHALMOLOGY is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the dynamic and evolving field of ophthalmology. With an impressive impact factor and a prestigious Q1 ranking in both Medicine (miscellaneous) and Ophthalmology for 2023, this journal is recognized for its authoritative reviews and critical summaries of contemporary research. Since its inception in 1990, the journal has served as an essential resource for ophthalmology professionals, providing insights into the latest advances in clinical practices, emerging technologies, and cutting-edge research. Although not open access, it is highly regarded for its rigorous peer-review process, ensuring the publication of high-quality, relevant findings. Researchers, clinicians, and students alike will find invaluable perspectives in its pages as they navigate the complexities of eye health and patient care.

The International Journal of Retina and Vitreous, published by BMC, stands as a premier open-access platform dedicated to advancing the field of ophthalmology, specifically focusing on retina and vitreous research. Established in 2015, this journal has swiftly positioned itself within the academic community, achieving a commendable Q2 category ranking in Ophthalmology for 2023, and ranks #49 out of 137 in Scopus for Medicine - Ophthalmology, indicating its growing influence and reach within the scientific landscape. The journal is committed to disseminating high-quality research, reviews, and clinical insights that explore innovations, challenges, and breakthroughs in ocular health. With the goal of fostering knowledge exchange among researchers, practitioners, and students, the International Journal of Retina and Vitreous promotes an open-access model, ensuring that vital findings are readily available to a global audience. This journal not only serves as a vital resource for advancing the understanding and treatment of retinal and vitreous diseases but also aims to inspire future studies in this critical area of eye health.

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.

Ophthalmologie is a distinguished journal published by Springer Heidelberg, specializing in the broad and evolving field of ophthalmology. With an ISSN of 2731-720X and an E-ISSN of 2731-7218, the journal serves as a pivotal platform for disseminating cutting-edge research and clinical advancements in the realm of eye health. As of 2023, it ranks in the third quartile (Q3) within both the general medicine and ophthalmology categories, reflecting its substantial contribution to the academic community and the field's knowledge base. The journal aims to foster collaboration among researchers, medical professionals, and students by offering innovative findings that enhance understanding and treatment of ocular diseases. By nurturing high-quality scholarly discussions, Ophthalmologie plays an essential role in the ongoing development of therapeutic strategies and ophthalmic techniques that ultimately benefit patient care globally. This commitment to excellence is evident as it continues to evolve through its convergence from 1992 to 2023, staying relevant in an ever-changing scientific environment.

Japanese Journal of Ophthalmology, published by Springer Japan KK, is a premier peer-reviewed journal dedicated to advancing the field of ophthalmology. With an impressive impact reflected in its Q1 categories—ranking among the top journals in both Medicine (miscellaneous) and Ophthalmology, as per the 2023 metrics—it serves as an essential platform for researchers and professionals to disseminate their findings. Covering a broad spectrum of topics from clinical studies to innovative technologies in eye care, this journal not only supports the ongoing education of its readership but also fosters significant developments within the field. The journal, which has been in circulation since 1973 and is set to continue through 2024, offers access to vital research, thereby enabling practitioners and scholars to keep abreast of the latest advancements. Its distinguished Scopus ranking of #30 out of 137 in Medicine - Ophthalmology, placing it in the 78th percentile, further underscores its influence and importance in contributing to the global understanding of eye health.

Augenheilkunde Up2date is a pivotal journal in the field of ophthalmology, published by GEORG THIEME VERLAG KG, a renowned publisher known for its commitment to advancing medical knowledge. With its ISSN 1616-9719 and E-ISSN 1616-9735, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and nuanced discussions in eye health. Although not available as open access, its curated content offers significant insights into contemporary research, clinical practices, and emerging trends in ophthalmology, thus promoting the continuous professional development of its readers. There is an emphasis on providing comprehensive reviews that encapsulate the pertinent advancements in the field, making it an essential publication for those aiming to enhance their expertise in eye care and vision science.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.

Turk Oftalmoloji Dergisi - Turkish Journal of Ophthalmology is a premier peer-reviewed publication dedicated to the field of ophthalmology, published by GALENOS PUBL HOUSE. Since its inception in 1997, this Open Access journal has championed the dissemination of high-quality research, fostering an inclusive environment for sharing knowledge and advancements in eye health. With an ISSN of 1300-0659 and an E-ISSN of 2147-2661, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest findings and innovations in ophthalmic sciences. Although its coverage in Scopus has been discontinued since 2017, the journal has garnered a significant rank of 80 out of 114 in the field of Medicine – Ophthalmology, highlighting its relevance and impact within the discipline. Operating out of Istanbul, Turkey, the Turkish Journal of Ophthalmology continues to be a crucial platform for ophthalmologists and researchers to publish their work and advance the understanding of ocular health.